1. |
Hunter T, Pines J. Cyclins and cancer. Ⅱ: Cyclin D and CDK inhibitors come of age [J].Cell, 1994; 79(4)∶573.
|
2. |
Polyak K, Lee MH, ErdjumentBromage H, et al. Cloning of p27Kip1,a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals [J].Cell,1994; 78(1)∶59.
|
3. |
Toyoshima H, Hunter T. p27,a novel inhibitor of G1 cyclinCdk protein kinase activity,is related to p21 [J]. Cell, 1994; 78(1)∶67.
|
4. |
Loda M, Cukor B, Tam SW, et al. Increased proteasomedependent degradation of the cyclindependent kinase inhibitor p27 in aggressive colorectal carcinomas [J]. Nat Med, 1997; 3(2)∶231.
|
5. |
Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cellcycle inhibitor p27Kipl protein: prognostic implications in primary breast cancer [J].Nat Med, 1997; 3(2)∶227.
|